Biotech

All Articles

Boundless Bio creates 'small' cutbacks five months after $100M IPO

.Merely 5 months after getting a $100 million IPO, Vast Biography is already laying off some employe...

Halda's $126M is going to evolve 'secure and eliminate' lump medications

.The preliminary stages of oncology R&ampD may not be except appealing new methods, and Halda Rehabs...

Lykos 'disappointments' certainly not making known research transgressions with publisher

.Psychopharmacology has taken 3 short articles concerning midstage professional trial data evaluatin...

Analysts examine Avidity's DMD gain, revealing subtleties in information

.Avidity Biosciences impressed clients along with phase 1/2 data in Duchenne muscular dystrophy (DMD...

Actinogen's cortisol blocker neglects phase 2 depression research study

.Actinogen Medical's cortisol blocker has actually overlooked the key endpoint of a period 2 study i...

Bivictrix decides going personal only means to take ADC into clinic

.Antibody-drug conjugates (ADCs) have actually been at the center of many a billion-dollar biobuck l...

TPG leadings up funds to $580M for expenditures around life sciences

.Resource manager TPG, which has actually assisted biotechs like Sionna Rehabs and also Santa Clam A...

Merck ceases stage 3 TIGIT trial in lung cancer cells for futility

.Merck &amp Co.'s TIGIT plan has actually gone through another setback. Months after shuttering a pe...

After a tough year, Exscientia folds right into Recursion

.After a year specified by pipeline cuts, the variation of its own CEO as well as layoffs, Exscienti...

Cullinan, after $25M bargain, restore bispecific to Port

.Cullinan Therapeutics was actually thrilled enough along with Harbour BioMed's bispecific immune ac...